Edition:
United States

Proteon Therapeutics Inc (PRTO.OQ)

PRTO.OQ on NASDAQ Stock Exchange Global Market

1.90USD
8 Dec 2017
Change (% chg)

$0.10 (+5.56%)
Prev Close
$1.80
Open
$1.85
Day's High
$1.90
Day's Low
$1.85
Volume
9,029
Avg. Vol
10,508
52-wk High
$10.45
52-wk Low
$1.15

Chart for

About

Proteon Therapeutics, Inc. is a late-stage biopharmaceutical company, which focuses on the development of pharmaceuticals to address the needs of patients with renal and vascular disease. The Company is involved in research and development activities. The Company's product candidate, product candidate, vonapanitase, formerly... (more)

Overall

Beta: --
Market Cap(Mil.): $33.48
Shares Outstanding(Mil.): 17.62
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 186.11 15.67
EPS (TTM): -- -- --
ROI: -- -11.32 34.62
ROE: -- -35.69 16.00

BRIEF-Proteon Therapeutics Q3 ‍loss per share $1.08​

* Proteon Therapeutics announces third quarter 2017 financial results

Nov 07 2017

BRIEF-Proteon Therapeutics Q2 loss $0.33 per share

* Proteon Therapeutics announces second quarter 2017 financial results

Aug 07 2017

BRIEF-Proteon Therapeutics files for shelf offering of up to 22.1 million shares

* Proteon Therapeutics Inc files for shelf offering of up to 22.1 million shares of common stock by selling stockholders‍​ - sec filing Source text - http://bit.ly/2wpHLJ0 Further company coverage:

Aug 03 2017

BRIEF-Deerfield Management reports 6.97 pct stake in Proteon Therapeutics - SEC filing

* Deerfield Management Company L.P. reports 6.97 percent stake in Proteon Therapeutics Inc as of June 22 - SEC filing

Jun 29 2017

Earnings vs. Estimates